VolitionRx shareholders approve authorized share increase to 325M; all director nominees elected

VOLITIONRX LTD

Authorized common shares increased from 175M to 325M effective June 18, 2025, via Certificate of Second Amendment.
All eight director nominees elected with ~35-36M votes for each; about 14.7M broker non-votes.
Ratification of Sadler, Gibb & Associates as auditor passed with 51.3M votes for, 330k against.
Non-binding advisory vote on named executive officer compensation passed with 34.4M for, 2.3M against.
Charter amendment proposal passed with 49.5M votes for, 1.8M against, and 385k abstentions.

item 5.03item 5.07item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.